Location:Home /  Resource
Past list
ATOPlex Multiplex PCR Panel COVID-19
Release date:2021-03-05Writer:MGIViews:5145Share

As the COVID-19 pandemic continues to evolve, more and more sequencing power is needed to obtain the most up-to-date information on the virus. These information help to construct the transmission routes and the profiles of the most recent variants, effectively supporting large-scale surveillance efforts and research on different mutations of the virus.

Due to its high-throughput, massively parallel sequencing (MPS) has exhibited enormous capacity and will continue to contribute the surveillance, variation and evolution analysis of SARS-CoV-2.

ATOPlex is a MPS platform that applies MGI proprietary ultra-high multiplex PCR-based enrichment technique in customized panel design. It provides a streamlined workflow for complete genome sequencing and epidemiological study of SARS-CoV-2. After amplifying relevant genomic segments, subsequent sequencing on MGI's DNBSEQ platform achieves highly accurate coronavirus genotyping. The platform also includes ATOPlex RNA Library Prep Set, a reagent that converts viral RNA to sequencing libraries in 5 hours. It is suitable for population-scale virus detection, surveillance and tracing.

Dr. Yao Jiang & Dr. Monta Ustinova
MGI senior product manager; Latvian Biomedical Research and Study Centre Research Assistant

If you have any questions, you can send an email to:
  • Hotline (Global)
  • Email
  • Special Recommendations
  • *For research use only.

    Not for use in diagnostic procedures (except as specifically noted).
Copyright © 2024 All Rights Reserved MGI Tech Co., Ltd. Guangdong ICP 16117185Privacy PolicyLegal NoticesCookie Policy
Our use of cookies
We would like to use necessary cookies to improve your browsing experience and the quality of our website. We would also like to set analytics cookies and advertisement cookies that help us make improvements by measuring how you use our website. Detailed information about the use of cookies on this website and how you can control your consent can be found in our Cookie Policy and Privacy Policy.
Accept only strictly necessary cookiesAccept all cookies